PCR & NGS Based Diagnostic Testing Market

PCR & NGS Based Diagnostic Testing Market Size, Share, Growth Analysis, By Product(Consumables, Equipment), By End-use(Hospital and clinics, Diagnostic centers), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35A2701 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

PCR & NGS Based Diagnostic Testing Market Insights

Market Overview:

In 2020, the market size of PCR and NGS-based diagnostic testing surpassed USD 21.5 billion, and it is projected to experience a compound annual growth rate (CAGR) of over -0.2% from 2021 to 2027. This technology utilizes Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) techniques to detect and analyze genetic material, enabling accurate and efficient diagnosis of various diseases. The anticipated growth indicates the continued importance and adoption of PCR and NGS-based diagnostic testing in the healthcare industry over the forecast period.

PCR & NGS Based Diagnostic Testing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for PCR & NGS Based Diagnostic Testing was estimated to be valued at US$ XX Mn in 2021.

The global PCR & NGS Based Diagnostic Testing Market is estimated to grow at a CAGR of XX% by 2028.

The global PCR & NGS Based Diagnostic Testing Market is segmented on the basis of Product, End-use, Region.

Based on region, the global PCR & NGS Based Diagnostic Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global PCR & NGS Based Diagnostic Testing Market are , Agilent Technologies Inc. , Bio-Rad Laboratories Inc. , Eppendorf AG , Fluotics , Hamilton Company , Illumina Inc. , Integra LifeScience Holdings Corporation , MGI Tech Co.Ltd , Mascon Inc. , Qiagen Inc , Roche Diagnostics , Thermo Fisher Scientific , Thomas Scientific (The Carlyle Group) , VWR International (Avantor, Inc.).

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

PCR & NGS Based Diagnostic Testing Market

Product ID: UCMIG35A2701

$5,300
BUY NOW GET FREE SAMPLE